@Ken Turnbull ,
I am wondering how reliable this test is as clinical information. Novak seems to have created this category of orthostatic cerebral hypo perfusion but I do not see any clear indication that it is meaningful. About 10% of a retrospective series were designated as this, having showed a greater drop in perfusion measured by doppler than the others, but it is not clear to me whether this is more than just natural variation in results on a population. It is also unclear to me whether it means anything clinically.
There is a study from 1995 that confirms that doppler measures blood flow in a way that correlates with a more reliable PET method but it did not correlate with brain metabolism, so it may not tell you anything about availability of oxygen.
I know very little about this field but wonder if it is really validated. Has anyone other than Novak confirmed the validity of the concept and the clinical relevance of the test?
I'm sorry it's taken me a while to log back in and reply.
There are various researchers who have reported abnormal levels of cerebral hypoperfusion in patients with orthostatic intolerance on tilt table testing, including in patient groups that have other signs that can be measured as abnormal during the test (e.g. blood pressure, heart rate).
There are a couple of research groups who used other measurement modalities, or more than one modality.
As to whether the entity of OCHOS (cerebral hypoperfusion in the absence of any other signs or previously known causes) can be said to be validated, I'm not sure.
There was a South Korean group who seem to have found the same entity, although they called it OINH.
https://pubmed.ncbi.nlm.nih.gov/26427910/
And Visser, van Campen et al have reported on what seems to be the same entity in their work with ME/CFS patients.
But these might all be retrospective studies.
I agree it needs more work.
You probably saw the recent thread about the letter to the editor on the subject:
https://www.s4me.info/threads/is-it...ing-head-up-tilt-testing-2024-mitchell.38582/
The authors acknowledge various problems with using Doppler ultrasound, although I don't think they answer your question about clinical relevance.
Can PET be done standing up?
Nobody really mentions oxygenation or metabolism. I think those topics might be more relevant to ME/CFS, in which cerebral hypoperfusion isn't the only problem affecting brain function.
***
On an anecdotal note, my daughter improved suddenly upon taking a vasodilator, after 18 years of OI symptoms, and Dr Novak has stated that hypertensive-type OCHOS responds to vasodilators.
As an observer, I saw the colour return to her face and her old self returning.
There is a lot more to the story, and my daughter could probably write an essay on all the things that were considered and ruled out over the past five years, but suffice to say OCHOS is the only diagnosis left on the table that matches her situation.
If we find out anything to the contrary, we will of course revise that. But for now she is feeling somewhat better on vasodilators, although she is limited to a less-than-ideal dose by side effects.
EDIT: Just realised I made a mistake in my post. "Cerebral hypoperfusion" is of course by definition abnormal. What I meant was that researchers noticed a more marked drop in cerebral blood flow than that experienced by healthy controls of the same age. I have read that there is a lack of normative data, but in the studies I looked at controls would experience a drop of up to 10% and those with orthostatic intolerance would experience a drop of about 20%.
(Studies were from Visser, van Campen et al and Novak.)